Shares of LifePoint Hospitals Inc. (NASDAQ:LPNT) have earned an average rating of “Hold” from the nineteen brokerages that are covering the company. Three analysts have rated the stock with a sell recommendation, nine have given a hold recommendation and seven have assigned a buy recommendation to the company. The average 12 month price target among brokers that have covered the stock in the last year is $68.75.

A number of brokerages recently weighed in on LPNT. Mizuho reduced their price objective on LifePoint Hospitals from $61.50 to $56.00 and set a “neutral” rating on the stock in a research report on Monday, August 1st. Zacks Investment Research lowered LifePoint Hospitals from a “buy” rating to a “hold” rating in a research report on Friday. Raymond James Financial Inc. reduced their price objective on LifePoint Hospitals from $75.00 to $65.00 and set an “outperform” rating on the stock in a research report on Tuesday, August 2nd. Wedbush restated a “neutral” rating and set a $66.00 price objective (down previously from $80.00) on shares of LifePoint Hospitals in a research report on Monday, August 1st. Finally, Royal Bank Of Canada reduced their price objective on LifePoint Hospitals from $84.00 to $77.00 and set an “outperform” rating on the stock in a research report on Monday, August 1st.

LifePoint Hospitals (NASDAQ:LPNT) opened at 53.75 on Tuesday. LifePoint Hospitals has a 12 month low of $51.50 and a 12 month high of $75.94. The stock has a market cap of $2.16 billion, a PE ratio of 18.17 and a beta of 0.95. The company’s 50 day moving average is $59.18 and its 200 day moving average is $62.33.

LifePoint Hospitals (NASDAQ:LPNT) last issued its quarterly earnings data on Friday, October 28th. The company reported $0.94 earnings per share for the quarter, topping analysts’ consensus estimates of $0.84 by $0.10. The business had revenue of $1.59 billion for the quarter, compared to analyst estimates of $1.59 billion. LifePoint Hospitals had a return on equity of 7.02% and a net margin of 1.93%. LifePoint Hospitals’s quarterly revenue was up 21.1% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.97 EPS. On average, analysts anticipate that LifePoint Hospitals will post $3.59 EPS for the current fiscal year.

Hedge funds and other institutional investors have recently bought and sold shares of the company. Victory Capital Management Inc. increased its stake in shares of LifePoint Hospitals by 65.2% in the third quarter. Victory Capital Management Inc. now owns 1,692 shares of the company’s stock valued at $100,000 after buying an additional 668 shares during the period. Fuller & Thaler Asset Management Inc. bought a new stake in shares of LifePoint Hospitals during the second quarter valued at approximately $111,000. Pacad Investment Ltd. bought a new stake in shares of LifePoint Hospitals during the second quarter valued at approximately $141,000. US Bancorp DE increased its stake in shares of LifePoint Hospitals by 1.6% in the second quarter. US Bancorp DE now owns 2,316 shares of the company’s stock valued at $152,000 after buying an additional 37 shares during the period. Finally, Tower Research Capital LLC TRC increased its stake in shares of LifePoint Hospitals by 1,006.8% in the third quarter. Tower Research Capital LLC TRC now owns 2,756 shares of the company’s stock valued at $163,000 after buying an additional 2,507 shares during the period. 94.26% of the stock is currently owned by institutional investors and hedge funds.

About LifePoint Hospitals

LifePoint Health, Inc, formerly LifePoint Hospitals, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers and post-acute facilities. The Company operates through healthcare services segment. The Company operates over 70 hospital campuses in over 20 states, having a total of over 8,240 licensed beds.

5 Day Chart for NASDAQ:LPNT

Receive News & Stock Ratings for LifePoint Hospitals Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifePoint Hospitals Inc. and related stocks with our FREE daily email newsletter.